Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.1 (
protein kinase
)
81,284
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Although some studies have supported the effects of caffeine for treatment of Attention deficit and hyperactivity disorder (ADHD), there were no evidences about its effects at the neuronal level. In this study, we sought to find morphological alterations during in vitro development of frontal cortical neurons from Spontaneoulsy hypertensive rats (SHR, an ADHD rat model) and Wistar-Kyoto rats (WKY, control strain). Further, we investigated the effects of caffeine and adenosine A
1
and A
2A
receptors (A
1
R and A
2A
R) signaling. Cultured cortical neurons from WKY and SHR were analyzed by immunostaining of microtubule-associated protein 2 (MAP-2) and tau protein after treatment with either caffeine, or A
1
R and A
2A
R agonists or antagonists. Besides, the involvement of PI3K and not
PKA
signaling was also assessed. Neurons from ADHD model displayed less neurite branching, shorter maximal neurite length and decreased axonal outgrowth. While caffeine recovered neurite branching and elongation from ADHD neurons via both
PKA
and PI3K signaling, A
2A
R agonist (CGS 21680) promoted more neurite branching via
PKA
signaling. The selective A
2A
R antagonist (
SCH
58261) was efficient in recovering axonal outgrowth from ADHD neurons through PI3K and not
PKA
signaling. For the first time, frontal cortical neurons were isolated from ADHD model and they presented disturbances in the differentiation and outgrowth. By showing that caffeine and A
2A
R may act at neuronal level rescuing ADHD neurons outgrowth, our findings strengthen the potential of caffeine and A
2A
R receptors as an adjuvant for ADHD treatment.
...
PMID:Caffeine and adenosine A
2A
receptors rescue neuronal development in vitro of frontal cortical neurons in a rat model of attention deficit and hyperactivity disorder. 3175 36
<< Previous
1
2
3
4
5
6
7
8
9